Fitting a key into a lock may seem like a simple task, but researchers
at Texas A&M University are using a method that involves testing
thousands of keys to unlock the functions of enzymes, and their
findings could open the door for new targets for drug designs.
Texas
A&M researcher Frank Raushel is part of a team of scientists who
modified a technique called "molecular docking" to predict which
molecule, called a substrate, triggers an enzyme into action, enabling
them to decipher an enzyme's function based on its structure alone.
The team's paper was published in the journal Nature.
Most
biological processes depend on enzymes, which are proteins that speed
up chemical reactions, but the function of many enzymes remains a
mystery.
"There are thousands of molecules that could be
substrates [for a specific enzyme], and it would take too long to
physically test them all," Raushel said. "So we decided there was a
need for a new method to determine the function of enzymes."
The
team started with the three-dimensional X-ray structure of an enzyme
and then used a computer to try to fit different smaller molecules into
the active site of the enzyme like pieces in a puzzle.
"Each
enzyme has a specific size and shape," Raushel said, "and you can use a
computer to take small molecules and fit them into the active site of
an enzyme one by one and score them on how well they fit. It's more or
less like fitting a key into a lock, but a lot more difficult since
both the enzyme and the substrate are conformationally flexible."
After
the computer scores the molecules on how well they fit the enzyme, it
ranks their order, and the researchers can then use the prioritized
list to decide which molecules to physically test.
"As far as we
know, this is the first time anybody has used molecular docking to
predict the function of an enzyme," Raushel said. "And it was verified
by both experiment and X-ray crystallography."
Other methods
researchers use to try to determine an enzyme's function or substrate
specificity include physically testing thousands of possible molecules,
gathering information from the nearby genes, and comparing the
structure of the enzyme to that of other enzymes with known functions.
"I think that in the end, we'll have to use all of these methods
together," Raushel said. "One single method just won't suffice."
Raushel and his team plan to continue using their molecular docking method to find the function of other enzymes.
"We're
looking at other X-ray structures of proteins that have unknown
functions, and we're working to fill the gap," Raushel said. "We're
trying to see how general this method is going to be or if we were just
lucky in this particular case."
Raushel and Texas A&M
post-doctoral associate Ricardo Marti-Arbona work in conjunction with
Brian Shoichet at the University of California, San Francisco, and
Steven Almo from the Albert Einstein College of Medicine in New York.
Raushel hopes that over the next five years, the team can start to use its findings to locate potential targets for new drugs.
"Understanding
the substrate specificity of certain enzymes could allow researchers to
differentiate enzymes that catalyze one reaction in pathogenic
organisms and a slightly different reaction in human systems," Raushel
said. "This would allow scientists to design [drugs] that would
specifically target a pathogenic organism while not affecting the human
enzyme."
Texas A&M University. November 2007.